Trial Profile
Omalizumab in patients with allergic asthma and higher baseline IgE levels
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Sep 2015
Price :
$35
*
At a glance
- Drugs Omalizumab (Primary)
- Indications Allergic asthma
- Focus Therapeutic Use
- 05 Nov 2010 New trial record.